Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The PA process involves submitting clinical documentation that demonstrates the patient meets the payer specific coverage criteria before the drug is dispensed or administered
order: 100 pieces 217 sold Guangzhou Kaiyuan Biotechnology Co., Ltd
According to the results from in vitro and in vivo studies, tanshinone IIA pretreatment protects the liver from APAP-induced liver injury by activating Nrf2 and increasing the mRNA and protein levels of the Nrf2 target genes glutamate-cysteine ligase catalytic subunit (GCLC), NQO1, and HO-1 (Wang et al., 2016)
As a dual GIP/GLP-1 receptor agonist, it activates two metabolic pathways simultaneously, producing average weight loss of 20.9% in clinical trials
It is recommended to monitor the GPT to monitor hepatic injury
Diagnosis Early diagnosis is important to avoid the possibility of permanent neurological dysfunction and serious liver disease
US$ 24.88
US$ 23.28
US$ 20.40
US$ 26.95
US$ 29.69
US$ 25.97
US$ 26.63
US$ 22.05
US$ 26.22
US$ 23.98
US$ 20.54
US$ 23.78
US$ 23.77
US$ 28.09
